

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $157.24
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 23, 26 |
| Truist Securities |
| maintain |
| Hold |
| Hold |
| May 4, 26 | Truist Securities | maintain | Hold | Hold |
| Oct 24, 25 | Truist Securities | maintain | Hold | Hold |
| Apr 2, 25 | Truist Securities | downgrade | Buy | Hold |
| Feb 21, 25 | Goldman Sachs | maintain | Neutral | Neutral |
| Feb 21, 25 | Truist Securities | maintain | Buy | Buy |
| Sep 25, 24 | Truist Securities | maintain | Buy | Buy |
| Feb 23, 24 | Truist Securities | maintain | Buy | Buy |
| Nov 28, 23 | Truist Securities | maintain | Buy | Buy |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 68.37 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 89.47 | Oscillator | Sell |
| Williams %R (14) | -8.83 | Oscillator | Sell |
| MACD (12, 26, 9) | 2.91 (Hist 2.47) | Oscillator | Strong Buy |
| Average Directional Index (14) | 23.92 (+DI 34.7 / -DI 13.7) | Trend | Buy |
| EMA 20 | 145.59 | MA | Strong Buy |
| SMA 20 | 142.04 | MA | Strong Buy |
| EMA 50 | 146.14 | MA | Strong Buy |
| SMA 50 | 145.56 | MA | Strong Buy |
| SMA 200 | 160.06 | MA | Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 11, 26 | Boglioli Elsy Lisa | director | S-Sale | 900 @ $150.22 | $135.2K |
| Jun 4, 26 | Boglioli Elsy Lisa | director | F-InKind | 138 @ $156.10 | $21.54K |
| Jun 4, 26 | Costamagna Claudio | director | F-InKind | 207 @ $156.10 | $32.31K |
| Jun 3, 26 | Zelenka Janet | director | A-Award | 1,616 | — |
| Jun 3, 26 | Steigerwalt Eric T | director | A-Award | 1,616 | — |
| Jun 3, 26 | Robinson Stephen C | director | A-Award | 1,616 | — |
| Jun 3, 26 | Boglioli Elsy Lisa | director | A-Award | 1,616 | — |
| Jun 3, 26 | Seeger Laureen | director | A-Award | 371 | — |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
Healthcare compliance expert brings more than 25 years of experience in corporate governance, investigations and fraud and abuse matters Healthcare compliance expert brings more than 25 years of experience in corporate governance, investigations and fraud and abuse matters
FTI Consulting's diversified demand, AI opportunities & share buybacks support growth, but rising talent costs, margin pressure & higher debt pose challenges.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | 2.17 | 2.16 | Miss -0.5% | $993.5M |
| Apr 30, 2026 | 2.11 | 1.90 | Miss -10.0% | $983.3M |
| Feb 26, 2026 | 1.39 | 1.78 | Beat 28.1% | $990.7M |
| Oct 23, 2025 | 1.93 | 2.60 | Beat 34.7% | $956.2M |
| Jul 24, 2025 | 1.87 | 2.13 | Beat 13.9% | $943.7M |
| Apr 24, 2025 | 1.79 | 2.29 | Beat 27.9% | $898.3M |
| 8-K | Jul 31, 2026 | 2026-07-31 16:31:12 | View |
| 10-Q | Jul 30, 2026 | 2026-07-30 07:30:04 | View |
| SC 13G/A | Jul 24, 2026 | 2026-07-24 14:12:16 | View |
| 8-K | Jul 1, 2026 | 2026-07-01 07:40:27 | View |
| 4 | Jun 8, 2026 | 2026-06-08 15:43:30 | View |
| 4 | Jun 8, 2026 | 2026-06-08 15:43:24 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | FCN | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 19.2x | 22.7x · sector 18.4x | In line |
| Forward P/E (FY26E) | 17.0x | EPS est. 9.27 | In line |
| Price / Book | 3.7x | 3.2x | Elevated |
| Price / Sales | 1.1x | 1.8x | Discount |
| EV / EBITDA | 12.5x | 14.9x | Discount |
| Return on equity | 15.6% | — | Healthy |
| Gross margin | 31.8% | 31.9% | In line |
| Debt / Equity | 0.95 | 0.26 | Moderate |
| Piotroski / Altman Z | 6/9 | Z 3.51 | Safe zone |
Discounted cash flow model